Kim De Keersmaecker/ LinkedIn
Jun 13, 2026, 17:11
Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
Kim De Keersmaecker, Full Professor in Oncology at KU Leuven, shared a post on LinkedIn:
“Fantastic to attend the 2026 European Hematology meeting (EHA2026) in Stockholm with such a nice delegation from our Leuven Kankerinstituut focus group Hematology!
Like every year, it is really stimulating to have hematology clinicians and researchers united to share the most fascinating novel developments in our field.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments